(Q40929964)

24 September 2017

Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination (English)

1 reference

24 September 2017

5

1 reference

24 September 2017

Magalie Dosset

1

1 reference

24 September 2017

Charline Vauchy

series ordinal

2

1 reference

24 September 2017

Laurent Beziaud

series ordinal

3

1 reference

24 September 2017

Olivier Adotevi

series ordinal

4

1 reference

24 September 2017

language of work or name

1 reference

1 March 2013

1 reference

24 September 2017

1 reference

24 September 2017

2

1 reference

24 September 2017

3

1 reference

24 September 2017

e23430

1 reference

Universal cancer peptide-based therapeutic vaccine breaks tolerance against telomerase and eradicates established tumor

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661170

The immune contexture in human tumours: impact on clinical outcome

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661170

Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661170

Peptide epitope identification for tumor-reactive CD4 T cells

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661170

Multiple roles for CD4+ T cells in anti-tumor immune responses

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661170

Telomerase and cancer therapeutics

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661170

CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661170

Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661170

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661170

Tumor-Specific CD4+ T Cells Render the Tumor Environment Permissive for Infiltration by Low-Avidity CD8+ T Cells

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23802085

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/ONCI.23430

1 reference

24 September 2017

1 reference

24 September 2017

PubMed publication ID

23802085

1 reference